Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2017

01-11-2017 | Review

Does obesity modify the relationship between physical activity and breast cancer risk?

Authors: S. E. Neil-Sztramko, T. Boyle, E. Milosevic, S. F. Nugent, C. C. Gotay, K. L. Campbell

Published in: Breast Cancer Research and Treatment | Issue 2/2017

Login to get access

Abstract

Purpose

With only 5–10% of breast cancer cases attributed to genetic inheritance, prevention efforts have focused on modifiable risk factors. Physical activity plays a role in reducing breast cancer risk; however, the interaction between physical activity and other modifiable risk factors, such as obesity, has received little attention.

Methods

A systematic review and meta-analysis was conducted of studies examining the relationship between physical activity and breast cancer and how it may be modified by body mass index (BMI).

Results

A total of 29 papers were included: 18 were cohort and 11 were case–control studies. Overall, a significant reduction in the relative risk of breast cancer was found in postmenopausal women with high versus low levels of physical activity for women with a BMI <25 kg/m2 (RR 0.85, 95% CI 0.79, 0.92) and ≥25 kg/m2 (RR 0.87, 95% CI 0.81, 0.93) but not ≥30 kg/m2 (RR: 0.93, 95% CI 0.76, 1.13). Physical activity was not associated with a significant reduction in risk of breast cancer in premenopausal women in any BMI group.

Conclusion

The results of this meta-analysis suggest that physical activity is associated with a larger breast cancer risk reduction among women who are normal weight or overweight than among women who are obese. Since the included studies used diverse methods for assessment of physical activity and categories of BMI, results should be interpreted with caution and additional work is needed.
Appendix
Available only for authorised users
Literature
1.
DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62CrossRefPubMed
2.
Canadian Cancer Statistis (2014) Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Society, Toronto
3.
Lynch HT, Silva E, Snyder C, Lynch JF (2008) Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes. Breast J 14(1):3–13CrossRefPubMed
4.
Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P (2008) Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 122(3):481–485CrossRefPubMed
5.
6.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1999) Hormonal contraception and post-menopausal hormonal therapy, vol 72. IARC, Lyon
7.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2004) Tobacco smoke and involuntary smoking, vol 83. IARC Press, Lyon
8.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy, vol 91. International Agency for Research on Cancer, Lyon, pp 1–528
9.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2010) Alcohol consumption and ethyl carbamate, vol 96. International Agency for Research on Cancer, Lyon
10.
Vainio H, Kaaks R, Bianchini F (2002) Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 11(Suppl 2):S94–S100PubMed
11.
World Cancer Research Fund/American Institute for Cancer Research (2009) Policy and action for cancer prevention. World Cancer Research Fund/American Institute for Cancer Research, Washington, DC
12.
Colditz GA, Bohlke K (2014) Priorities for the primary prevention of breast cancer. CA Cancer J Clin 64(3):186–194CrossRefPubMed
13.
World Cancer Research Fund/American Institute for Cancer Research (2010) Continuous update project report. Food, nutrition, physical activity, and the prevention of breast cancer. World Cancer Research Fund/American Institute for Cancer Research, Washington, DC
14.
Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13–42CrossRefPubMed
15.
Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215CrossRefPubMed
16.
Thune I, Furberg AS (2001) Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc 33(6):S530–S550 (Discussion S510–S609) CrossRefPubMed
17.
Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42(8):636–647CrossRefPubMed
18.
Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J (2008) Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life. Cancer Epidemiol Biomarkers Prev 17(12):3402–3410CrossRefPubMed
19.
Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, Wing R, Schatzkin A (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101(9):630–643CrossRefPubMedPubMedCentral
20.
21.
Carmichael AR (2006) Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113(10):1160–1166CrossRefPubMed
22.
Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E et al (2016) Weight status and alcohol intake modify the association between vitamin D and breast cancer risk. J Nutr 146(3):576–585CrossRefPubMed
23.
Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC (2015) Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort. Am J Clin Nutr 102(4):966–973CrossRefPubMed
24.
Pizot C, Boniol M, Mullie P, Koechlin A, Boniol M, Boyle P, Autier P (2016) Physical activity, hormone replacement therapy and breast cancer risk: a meta-analysis of prospective studies. Eur J Cancer 52:138–154CrossRefPubMed
25.
Schmidt S, Monk JM, Robinson LE, Mourtzakis M (2015) The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obes Rev 16(6):473–487CrossRefPubMedPubMedCentral
26.
Guyatt G, Busse J (2011) Tool to assess risk of bias in cohort studies. Hamilton
27.
Guyatt G, Busse J (2011) Tool to assess risk of bias in case-control studies. Hamilton
28.
Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1–30CrossRefPubMed
29.
Sterne JAC (2009) Meta-analysis in Stata: an updated collection from the Stata Journal. Stata Press, College Station
30.
Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13(2):279–292CrossRefPubMed
31.
Ennour-Idrissi K, Maunsell E, Diorio C (2015) Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Res 17(1):139CrossRefPubMedPubMedCentral
32.
Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan CR, Mason C, Imayama I, Kong A, Xiao L et al (2012) Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 30(19):2314–2326CrossRefPubMedPubMedCentral
33.
Pietilainen KH, Korkeila M, Bogl LH, Westerterp KR, Yki-Jarvinen H, Kaprio J, Rissanen A (2010) Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments. Int J Obes 34(3):437–445CrossRef
34.
Warner ET, Wolin KY, Duncan DT, Heil DP, Askew S, Bennett GG (2012) Differential accuracy of physical activity self-report by body mass index. Am J Health Behav 36(2):168–178CrossRefPubMedPubMedCentral
35.
Gotay CC, Katzmarzyk PT, Janssen I, Dawson MY, Aminoltejari K, Bartley NL (2012) Updating the Canadian obesity maps: an epidemic in progress. Can J Public Health 104(1):e64–e68PubMed
36.
Rothman KJ (2012) Epidemiology: an introduction, 2nd edn edn. Oxford University Press, New York
37.
Greenland S (2009) Interactions in epidemiology: relevance, identification, and estimation. Epidemiology 20(1):14–17CrossRefPubMed
38.
Knol MJ, Egger M, Scott P, Geerlings MI, Vandenbroucke JP (2009) When one depends on the other: reporting of interaction in case-control and cohort studies. Epidemiology 20(2):161–166CrossRefPubMed
39.
Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, Initiative S (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4(10):e297CrossRefPubMedPubMedCentral
Metadata
Title
Does obesity modify the relationship between physical activity and breast cancer risk?
Authors
S. E. Neil-Sztramko
T. Boyle
E. Milosevic
S. F. Nugent
C. C. Gotay
K. L. Campbell
Publication date
01-11-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4449-4

Other articles of this Issue 2/2017

Breast Cancer Research and Treatment 2/2017 Go to the issue

Erratum

Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients

Preclinical study

HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma

Clinical trial

Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study

Brief Report

Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

Brief Report

NanoString-based breast cancer risk prediction for women with sclerosing adenosis

Epidemiology

Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits